Cutler Group LP Illumina, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	SELL	$183.43 - $232.67 $2.82 Million - $3.58 Million	-15,400 Reduced 98.72%	200 $1,000
Q1 2023 May 01, 2023	BUY	$193.75 - $232.55 $58,125 - $69,765	300 Added 1.96%	15,600 $80,000
Q4 2022 Feb 07, 2023	SELL	$187.24 - $242.74 $3.3 Million - $4.27 Million	-17,600 Reduced 53.5%	15,300 $4,000
Q3 2022 Oct 25, 2022	BUY	$177.23 - $227.44 $4.66 Million - $5.98 Million	26,300 Added 398.48%	32,900 $123,000
Q2 2022 Aug 04, 2022	SELL	$181.58 - $368.0 $1.04 Million - $2.1 Million	-5,700 Reduced 46.34%	6,600 $6,000
Q1 2022 Apr 14, 2022	BUY	$303.87 - $423.8 $3.74 Million - $5.21 Million	12,300 New	12,300 $132,000
Q1 2020 May 07, 2020	SELL	$209.2 - $335.53 $481,160 - $771,718	-2,300 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$288.29 - $335.49 $259,461 - $301,941	900 Added 64.29%	2,300 $133,000
Q1 2019 May 10, 2019	SELL	$272.57 - $321.18 $2.04 Million - $2.41 Million	-7,500 Reduced 84.27%	1,400 $114,000
Q4 2018 Feb 05, 2019	BUY	$272.46 - $366.54 $81,738 - $109,962	300 Added 3.49%	8,900 $950,000
Q3 2018 Nov 07, 2018	BUY	$279.04 - $367.06 $223,232 - $293,648	800 Added 10.26%	8,600 $1.5 Million
Q2 2018 Aug 10, 2018	BUY	$228.17 - $292.07 $775,778 - $993,038	3,400 Added 77.27%	7,800 $740,000
Q1 2018 May 11, 2018	SELL	$209.54 - $253.91 $2.7 Million - $3.28 Million	-12,900 Reduced 74.57%	4,400 $312,000
Q4 2017 Jan 17, 2018	SELL	$202.23 - $230.03 $7.4 Million - $8.42 Million	-36,600 Reduced 67.9%	17,300 $320,000
Q3 2017 Oct 17, 2017	BUY	$172.3 - $213.93 $9.29 Million - $11.5 Million	53,900	53,900 $819,000

Others Institutions Holding ILMN

# of Institutions

904

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account